Hemophilia Treatment Market

Clairvoyance Research29 Sep, 2021Business

Hemophilia is a rare inherited bleeding disorder in which the blood does not clot properly which leads to spontaneous bleeding as well as bleeding following injuries or surgery. Blood contains proteins called clotting factors that help to stop bleeding. People with hemophilia have low levels of either factor VIII or factor IX. The severity of hemophilia that a person has is determined by the amount of factor in the blood. Lower the amount of the factor, the more likely it is that bleeding will occur which can lead to serious health problems. The treatment of hemophilia may involve prophylaxis, management of bleeding episodes, treatment of factor VIII inhibitors, and treatment & rehabilitation of hemophilia synovitis. Use of factor replacement products and other medications, including pain medications, is typically required.